Dr. Bhupesh Prusty, PhD, Group Leader in the Department of Microbiology at the University of Würzburg in Germany was recently awarded the Koichi Yamanishi Young Investigator Award for Excellence in Basic Science.
Conference Videos
Thank you to the presenters who agreed to make their presentations at the 9th International Conference on HHV-6 & 7 available to others. HHV-6 ANTIVIRAL THERAPY The Difficult Path Towards an HHV-6 Therapy Lieve Naesens, PhD, Laboratory of Virology and Chemotherapy, Rega Institute, KU Leuven, Belgium DIAGNOSTICS Diagnostic Tools and Algorithms for HHV-6 Infections in Immunocompromised Patients Agnes Gautheret Dejean, …
HHV-6 status determines effectiveness of interferon treatment in Multiple Sclerosis
The administration of immune agents to patients (known as Interferon-Beta-1b, or IFN-beta, therapy) has been widely used in the treatment and maintenance of multiple sclerosis (MS). Additionally, it is known that the risk of MS exacerbation is much higher in patients with active HHV-6 infection than in patients with a latent infection of the virus (Lafuente 2006, 2007; Chapenko 2003). …
7th International Conference on HHV-6 & HHV-7 held February 27-March 2, 2011
Over 120 researchers and clinicians from 18 countries gathered in Reston, Virginia. Work was presented on the most recent implications and findings of HHV-6 in a broad spectrum of research and clinical settings.
- Page 2 of 2
- 1
- 2